Filing Details

Accession Number:
0001235802-11-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-21 12:00:00
Reporting Period:
2011-01-21
Filing Date:
2011-01-21
Accepted Time:
2011-01-21 12:21:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1023024 Biosante Pharmaceuticals Inc BPAX Biological Products, (No Disgnostic Substances) (2836) 582301143
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238120 B Philip Donenberg 111 Barclay Blvd
Suite 280
Lincolnshire IL 60069
Sr. Vp Of Finance, Cfo & Sec'y No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-21 1,000 $1.88 42,322 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct